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The noncoding Xist RNA triggers silencing of one of
the two female X chromosomes during X inactivation
in mammals. Gene silencing by Xist is restricted to
a special developmental context in early embryos
and specific hematopoietic precursors. Here, we
show that Xist can initiate silencing in a lymphoma
model. We identify the special AT-rich binding
protein SATB1 as an essential silencing factor. Loss
of SATB1 in tumor cells abrogates the silencing func-
tion of Xist. In lymphocytes Xist localizes along
SATB1-organized chromatin and SATB1 and Xist
influence each other’s pattern of localization.
SATB1 and its homolog SATB2 are expressed during
the initiation window for X inactivation in ES cells.
Importantly, viral expression of SATB1 or SATB2
enables gene silencing by Xist in embryonic fibro-
blasts, which normally do not provide an initiation
context. Thus, our data establish SATB1 as a crucial
silencing factor contributing to the initiation of X
inactivation.
INTRODUCTION
Mammals compensate the different number of X chromosomes
between the sexes by X inactivation. One of the two female X
chromosomes becomes transcriptionally silent in a developmen-
tally regulated manner. The noncoding Xist RNA, which localizes
to the inactive X chromosome (Xi), initiates chromosome-wide
gene repression. Xist is required for the initiation of X inactivation
in early embryonic cells (Marahrens et al., 1997; Penny et al.,
1996), whereas in most differentiated cells the Xi is silenced in
a stable manner which is independent of Xist (Brown and Willard,
1994; Csankovszki et al., 1999). Therefore, X inactivation is sepa-
rated into an initiation and a maintenance phase. Several factors
that act in maintaining the silent state of the Xi have been identi-
fied, including the histone variant macroH2A (Costanzi and Pehr-
son, 1998; Mermoud et al., 1999; Rasmussen et al., 2000),
histone H4 hypoacetylation (Keohane et al., 1996), and DNADevmethylation (Sado et al., 2000, 2004). Recently, it has been
shown that the SmcHD1 protein is required for maintenance of
DNA methylation patterns and gene repression on the Xi (Blewitt
et al., 2008).
At the initiation of X inactivation chromosome-wide silencing
by Xist is initially reversible. In embryonic stem (ES) cells reacti-
vation of genes can be observed when Xist expression is
abolished (Wutz and Jaenisch, 2000). Gene silencing depends
on the 50-end of Xist which contains the repeat A sequence motif
(Wutz et al., 2002). Mutation of repeat A abolishes the gene
silencing function of Xist, but has no effect on Xist localization
to the chromosome. Several factors that have been observed
enriched on the Xi, such as Polycomb group complexes, are
recruited by Xist in the absence of repeat A. This shows that
these factors are not sufficient for gene repression, suggesting
that an additional pathway is engaged in the initiation of chromo-
some-wide silencing (Plath et al., 2003; Schoeftner et al., 2006).
No primary initiation factors have been identified to date.
The gene silencing function of Xist is restricted to cells of the
early embryo (Savarese et al., 2006). In most differentiated cells,
where the Xi is stably silenced, Xist expression can not initiate
gene silencing (Sado et al., 2004; Savarese et al., 2006; Wutz
and Jaenisch, 2000). We have previously observed that Xist
expression can initiate gene silencing in lineage-restricted
progenitor cells in the hematopoietic system of adult mice
(Savarese et al., 2006). Thus, a special developmental context
in the early embryo and the hematopoietic system exists in which
chromosome-wide silencing can be established. Why Xist
expression cannot establish silencing outside these develop-
mental windows is unknown. One possibility is that expression
of essential silencing factors is restricted to specific develop-
mental contexts. We reasoned that perhaps we could find
initiation factors by setting a condition where Xist could silence
outside the known developmental windows.
RESULTS
Xist Initiates Ectopic X Inactivation in Lymphoma Cells
and Blocks Tumor Growth
To assess whether an epigenetic context for Xist-mediated
silencing exists in cancer cells we used an inducible Xist allele
(TX), in which a tetracycline-inducible promoter is insertedelopmental Cell 16, 507–516, April 21, 2009 ª2009 Elsevier Inc. 507
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Induction of Xist expression from the single X chromosome
in TX/Y males causes X inactivation and consequently loss of
X-linked genes leads to cell death in the context of T cell progen-
itors, particularly CD4+ CD8+ thymocytes (Savarese et al., 2006).
We introduced the TX allele into a thymic lymphoma model,
which is triggered by an oncogenic NPM-ALK fusion protein
under the control of a CD4 promoter (Chiarle et al., 2003). The









B Figure 1. Xist Initiates Ectopic X Inactiva-
tion in Lymphoma Cells and Blocks Tumor-
igenesis
(A) Tumor growth was monitored in Doxycycline
(Dox)-treated (red) and untreated (black) nude
mice after subcutaneous injection of 2 3 106
NPM-ALK TX/Y R26rtTA/rtTA lymphoma cells
(n = 10). Error bars represent standard deviation.
(B) Tumor weight on Day 30 (n = 10).
(C and D) Tumor morphology (C) and TUNEL anal-
ysis ([D], green) of histological tumor sections
showing apoptotic cells in the Dox-treated mice.
Nuclei are counterstained with DAPI (blue). Scale
bar = 10 mm.
(E) Xist induction on day 12 after tumor graft (blue
arrow) causes remission of established tumors
(blue). Untreated tumors (black) and tumors
treated with Dox from day 2 after tumor graft
(red) are controls (n = 10). Error bars represent
standard deviation.
(F) NPM-ALK TX/Y R26rtTA/rtTA lymphoma cell
cultures on feeders on days 1 and 5 with and
without Dox. Scale bar = 50 mm.
(G) RT-PCR showing silencing of the X-linkedPgk1
andHprt genes after 48 hr of ectopic Xist induction
in NPM-ALK TX/Y R26rtTA/rtTA lymphoma cells.
(H and I) Combined RNA FISH immunofluores-
cence analysis showing colocalization of
H3K27me3 (H) and H2AK119ub1 (I) with Xist
RNA. Percentage of total cells is given in the
panels (n = 500). Scale bar = 5 mm.
lymphoma kinase (ALK) to the nucleo-
phosmin (NPM/B23) gene by a t(2;5)
translocation found in human anaplastic
large cell lymphoma (ALCL; Chiarle
et al., 2008; Morris et al., 1994). We
generated mice carrying the NPM-ALK
transgene, which were either hemizygous
TX/Y males or homozygous TX/TX
females for the inducible Xist allele and
homozygous for the Doxycycline-induc-
ible transactivator R26rtTA/rtTA expressed
from the ROSA26 locus (Savarese et al.,
2006). Thymic lymphomas developed
6–12 weeks after birth and consisted of
Thy 1.2+ B220 cells, which were mostly
CD4+ CD8+ and in some cases CD4
CD8. To measure the effect of Xist
induction on tumor growth we injected
1 3 106 lymphoma cells subcutaneously
into immunedeficient athymic nude mice
using Matrigel as a carrier (Azuma et al., 2005). Untreated recip-
ient mice developed lymphomas in all injection sites, whereas
Xist induction by Doxycycline completely blocked tumor growth
(Figures 1A–1C; see Figures S1D and S1E available online). TU-
NEL staining indicated that Xist induction triggered tumor cell
death (Figure 1D). Comparable results were obtained with
several independent primary lymphoma isolates including
a female tumor with a homozygous TX allele, where Xist could
be induced from both X chromosomes (Figure S2). To examine508 Developmental Cell 16, 507–516, April 21, 2009 ª2009 Elsevier Inc.
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Doxycycline after tumor establishment. When Doxycycline was
administered 12 days after the graft, tumor remission was
observed (Figure 1E). A control NPM-ALK X/Y R26rtTA/rtTA tumor
that does not carry the TX allele was unaffected by Doxycycline
treatment showing that tumor ablation was an effect of Xist
induction (Figure S3).
We confirmed these results with a second tumor paradigm
and injected 23 106 NPM-ALK TX/Y R26rtTA/rtTA lymphoma cells
into the tail vein of Rag2/ common-g/ immune compro-
mised mice. After 21 days mice treated with Doxycycline were
healthy and tumor-free, while untreated recipients showed
massive infiltration of tumor cells in several organs (Figure S4).
To investigate if Xist induction caused ectopic X inactivation,
we established several cell lines by culturing primary tumors
in the presence of IL-7 on OP9-derived feeder cells. We plated
3 3 105 cells and measured cell growth in the presence or
absence of Doxycycline. We observed that Xist induction from
the single male X chromosome (TX/Y) or both female X chromo-
somes (TX/TX) caused a loss of tumor cells (Figure 1F and Figure
S5A), whereas Doxycycline had no effect on control tumor cells
without the TX allele. Doxycycline treated male NPM-ALK TX/Y
R26rtTA/rtTA lymphoma cells showed Xist expression and a
marked loss of the X-linked gene expression (Figure 1G). Xist
clusters were detected in 98% of the cells induced with Doxycy-
cline, whereas no Xist focus was detected without induction
(Figure S5B). In over 90% of the cells Xist colocalized with trime-
thylated histone H3 lysine 27 (H3K27me3) and histone H2A
ubiquitinated on Lysine 119 (H2AK119ub1), which are two prom-
inent markers of the Xi (Figures 1H and 1I). These data showed
that Xist induction triggered ectopic X inactivation in lymphoma
cells equivalent to embryonic cells.
Identification of SATB1 as a Silencing Factor for Xist
We reasoned that the lymphoma context might provide an
opportunity for identifying initiation factors for Xist. For this we
aimed at generating a tumor that is resistant to Xist-mediated
killing. Tumor resistance is known to arise for virtually any thera-
peutic agent. Surprisingly, resistance to Xist-mediated killing
was not observed in our tumor grafts despite considerable
efforts. Therefore, we cultured lymphoma cells for 1 month in
the absence of Doxycycline to trigger tumor cell evolution.
Then 23 106 NPM-ALK TX/Y R26rtTA/rtTA cells were transplanted
into the flank of nude mice and tumor development was studied
in the presence of Doxycycline. Initially treated mice showed no
signs of tumor growth in stark contrast to control mice that did
not receive Doxycycline (Figure 2A). This is consistent with the
large majority of tumor cells being ablated by Xist induction.
However, after 21 days tumors started to appear at all injection
sites in Doxycycline-treated mice (Figure 2A and Figure S6A). It
is likely that these tumors originated from rare cells that acquired
resistance to Xist-mediated killing during in vitro culture. In histo-
logical tumor sections Xist clusters colocalizing with H3K27me3
foci were observed (Figure 2B). The X-linked Pgk1 and Hprt
genes were expressed at a level above or equal to that observed
in untreated control tumors or thymic cells (Figure 2C). The pres-
ence of one X chromosome per tumor cell was confirmed by
X chromosome painting ruling out the possibility that the resis-
tance to Xist-mediated killing was due to rearrangement orDevegain of X chromosomes (Figure S6B). Furthermore, Xist induction
by addition of Doxycycline did not affect proliferation of a cell line
established from this tumor (Figure S6C). These results sug-
gested that spontaneous resistance had arisen by loss of the
pathways required for the silencing function of Xist.
To identify genes that were associated with resistance to
Xist-mediated killing we performed genome-wide expression
profiling of Xist-responsive and Xist-resistant tumors and of
thymus (Figure 2D and Figure S7). Among the most significantly
downregulated genes in resistant tumors (Table S1) we noted
SATB1, a nuclear protein which functions in regulating chromatin
structure and gene regulation in thymocytes (Dickinson et al.,
1992; Alvarez et al., 2000; Cai et al., 2003). In thymus, expression
of SATB1 is high in the CD4+ CD8+ double-positive T cell
compartment, which we previously observed to possess the
context for initiation of gene silencing by Xist (Savarese et al.,
2006). This suggested a correlation of SATB1 expression and
gene silencing by Xist.
SATB1 Is Essential for the Silencing Function of Xist
in Thymocytes
To verify that SATB1 could be a limiting factor for the silencing
function of Xist we analyzed expression in development. In
thymus, high levels of SATB1 were found in the cortex, which is
predominantly composed of CD4+ CD8+ thymocytes, whereas
in the medulla fewer cells showed expression (Figures S8A and
S8B). This is consistent with a loss of SATB1 expression upon
further thymocyte differentiation to single positive T cells. To
test that SATB1 expressing cells in the thymus provided the
context for silencing by Xist, we induced Xist from the single
male X chromosome in TX/Y R26rtTA/rtTA mice. We observed
a rapid loss of SATB1 expressing cells uponXist induction consis-
tent with cell death caused by ectopic X inactivation (Figure S8C).
In NPM-ALK thymic lymphoma the normal thymic structure
was lost and substituted by blasts, which were positive for the
NPM-ALK protein and SATB1 (Figures S8A and S8B). Western
analysis confirmed a loss of SATB1 protein in Xist-resistant
tumors (Figure 3A). SATB1 immunohistochemistry in sections
revealed a ring-like pattern in the thymus and Xist-responsive
tumors, whereas Xist-resistant tumors showed no or minimal
SATB1 expression (Figure 3B). None of the resistant tumors
was positive for SATB1. To test if SATB1 was required for the
gene silencing function of Xist in lymphoma cells we performed
RNAi. RNAi in lymphoma cells was technically difficult and
required the optimization of the protocol. For efficient reduction
of SATB1 protein levels we used a double transfection protocol.
We transfected NPM-ALK TX/Y R26rtTA/rtTA lymphoma cells with
siRNA specific for SATB1 or control siRNA. After two days Xist
expression was induced and a second siRNA transfection was
performed 3 days thereafter. We measured the total cell
numbers of triplicate cultures with and without Doxycycline
induction after 5 days and calculated the percentage of surviving
cells after Xist induction. Cells transfected with SATB1 siRNAs
showed a significantly higher survival compared to controls
(Figure 3C and Figure S8D). Western and immunofluorescence
analysis showed reduced SATB1 expression in most cells
treated with SATB1 siRNA, but not control siRNA, confirming
the effect of the siRNA (Figure 3D and Figure S8E). SATB1
seemed to stabilize Xist RNA and thus after RNAi a reductionlopmental Cell 16, 507–516, April 21, 2009 ª2009 Elsevier Inc. 509
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localize onto SATB1 organized chromatin and is thereby stabi-
lized leading to higher Xist levels. However, we also note that
in the SATB1 siRNA-treated cells we observed efficient Xist
induction.
To test if SATB1 is sufficient to restore Xist silencing in




Figure 2. Derivation of an Xist-Resistant
Tumor for Identification of Silencing Factors
(A) Tumor growth after transplantation of 2 3 106
cultured NPM-ALK TX/Y R26rtTA/rtTA lymphoma
cells into nude mice. After 22 days (red arrow),
Xist-resistant tumors appear in the Dox-treated
group (red; n = 5). Error bars represent standard
deviation.
(B) Xist RNA FISH (red) and H3K27me3 (green) in
histological sections of the resistant tumor.
Percentage of colocalization is given.
(C) Quantitative RT- PCR analysis showing that the
X-linkedPgk1 andHprt genes are still expressed in
the resistant tumors when Xist is induced with Dox
at a comparable level to normal thymus or parental
tumor without Xist induction. Results were normal-
ized to Gapdh. Error bars represent standard
deviation (n = 3).
(D) Heatmap showing upregulated (red) and down-
regulated (green) genes after hierarchical clus-
tering of gene expression profiles of Xist-resistant
and Xist-responsive NPM-ALK TX/Y R26rtTA/rtTA
lymphoma and normal male thymus. Probes for
Xist and SATB1 are indicated (arrows) and gene
groups are annotated (right).
Xist-resistant tumor cell line. SATB1 ex-
pressing tumor cells showed a strongly
reduced survival upon Xist induction
compared to Xist-resistant tumor cells in-
fected with empty vector (Figures 3E and
3F). Taken together these data strongly
support a crucial function for SATB1 in
gene silencing by Xist in the lymphoid
and tumor context.
Xist Localizes along Nuclear SATB1
Structures in Lymphoid Cells
To investigate a potential interaction we
performed SATB1 immunofluorescence
analysis combined with Xist RNA FISH.
In thymocyte nuclei SATB1 is observed
in a ring-like structure (Cai et al., 2003).
We have previously observed that in
CD4+ CD8+ T cells, which constitute the
hematopoietic context for gene silencing
in the thymus, Xist does not form a char-
acteristic focus but appears in a diffuse
pattern (Savarese et al., 2006). Therefore,
we examined thymi from TX/Y R26rtTA/rtTA
mice after induction of Xist for 24 and
48 hr. Xist formed a characteristic focus
after 24 hr of induction. However, after
48 hr Xist spread along SATB1 in the majority of cells, whereby
it did not colocalize with but rather outlined the SATB1 ring
(Figure 3G and Figures S9A–S9E). In normal female thymocytes,
we observed the expected SATB1 ring structure and in more
than half of the cells Xist did not form a focus but localized along
the SATB1 ring (Figure S9F). This localization pattern of Xist is
therefore observed in a physiologically normal cell type.510 Developmental Cell 16, 507–516, April 21, 2009 ª2009 Elsevier Inc.
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observed in thymocytes isolated from SATB1-deficient mice,
where more Xist foci were observed (Figure 3H). Thus, delocal-
ization of Xist in thymocytes depends on SATB1.
Next we induced Xist expression in TX/TX R26rtTA/rtTA thymo-
cytes from both female X chromosomes. We observed two Xist
foci overlapped with two regions of intense SATB1 staining
(Figure S9G). Such a focal SATB1 pattern was not observed
before induction of Xist. This indicated that Xist expression
from two X chromosomes had caused a redistribution of
SATB1 from the ring. Thus, Xist and SATB1 apparently inter-
acted and changed each other’s localization.
In NPM-ALK TY/Y R26rtTA/rtTA lymphoma cells a characteristic
Xist focus was observed after 24 hr of induction whereas after






Figure 3. SATB1 Is a Critical Silencing
Factor for Xist in Lymphoma Cells
(A) Western analysis of SATB1 expression in Xist-
resistant and Xist-responsive tumor and normal
thymus. Actin serves as loading control.
(B) Immunohistochemistry in sections reveals
nuclear ring-like SATB1 structures in normal
thymus and Xist-responsive tumor, whereas
nuclear SATB1 staining is lost in resistant tumors.
(C) SATB1 RNAi in cultured NPM-ALK TX/Y
R26rtTA/rtTA lymphoma cells significantly increases
cell survival after Xist induction. Cell survival after
5 days of culture in presence of Dox relative to
uninduced cultures is plotted. Scrambled siRNA
treatment serves as control (n = 3). Error bars
represent standard deviation.
(D) Western analysis confirming loss of SATB1
protein in SATB1 siRNA treated but not scrambled
control siRNA treated cells. Lamin B serves as
loading control.
(E) Virally expressed SATB1 restores Xist silencing
function in Xist-resistant tumor cells. Cell survival
after 5 days of cultures in presence of Dox relative
to uninduced cultures is plotted. Empty vector-
infected cells serve as control (n = 3).
(F) Western analysis confirming SATB1 protein
expression in cells infected with SATB1 but not
control virus. Actin serves as loading control.
(G) Xist RNA FISH (red) combined with SATB1
immunofluorescence (green) analysis showing
Xist spreading along the SATB1 ring in TX/Y
R26rtTA/rtTA thymic cells after 48 hr of Xist induction
with Dox.
(H) Delocalization of Xist into a ring-like pattern is
observed in thymocytes of wild-type (WT) but not
SATB1 deficient female mice. Representative Xist
RNA FISH images are shown. A statistical analysis
of Xist patterns in SATB1 deficient and control
thymocytes is given (n = 150).
S10A). We further noted that the Poly-
comb group proteins Ring1B and Bmi1
were diffusely distributed in the nucleus
and showed partial overlap with SATB1
in a ring-like pattern (Figure S10B). We
suggest that the interaction between
Xist and SATB1 in lymphoma cells and
in normal thymocytes is potentially mediated by SATB1 orga-
nized chromatin. A direct physical attachment is unlikely, as
SATB1 and Xist RNA showed little overlapping localization.
SATB1 Regulates Xist Silencing Function
in Embryonic Cells
To analyze if SATB1 is relevant for the initiation of normal X inac-
tivation we analyzed mouse embryonic stem (ES) cells. Western
analysis showed SATB1 expression in ES cells, but 3 days after
retinoic acid induced differentiation SATB1 expression became
undetectable (Figure 4B). This expression precisely overlaps
the window in which Xist is able to silence (Wutz and Jaenisch,
2000). Immunofluorescence analysis showed that SATB1 was
diffusely distributed and surrounded a characteristic Xist focus
when Xist expression was induced in TX/Y ES cells (Figure 4A)Developmental Cell 16, 507–516, April 21, 2009 ª2009 Elsevier Inc. 511
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Figure 4. SATB1 Expression Defines the
Silencing Function of Xist in Embryonic
Cells
(A) Combined RNA FISH immunofluorescence
analysis of TX/Y R26rtTA/rtTA ES cells shows
SATB1 (green) surrounding the characteristic Xist
focus (red) after 24 hr of induction with Doxycy-
cline. Scale bar = 5 mm.
(B and C) Western analysis of SATB1 (B) and
SATB2 (C) protein during ES cell differentiation
shows that SATB1 is lost and SATB2 shifts to
a lower molecular weight on day 3, precisely
when Xist loses its silencing capability. Asterisk
indicates the high molecular weight form of
SATB2. Actin serves as loading control.
(D) Repression of the puromycin (puro) marker,
which is cointegrated with an Xist transgene on
chromosome 11 in clone 36 ES cells, upon Xist
induction is reduced by SATB1 or SATB2 RNAi
compared to scrambled control. Quantification of
puro expression after Xist induction relative to
uninduced cells is given.
(E) Western analysis demonstrates strongly
reduced SATB1 protein in ES cells treated with
SATB1 siRNA but not control siRNA. Western
analysis of SATB2 in ES cells treated with scram-
bles control, SATB2, and SATB1 siRNAs. The
higher molecular weight form of SATB2 (asterisk)
observed in ES cells is depleted by SATB2 RNAi.
The lower molecular weight form of SATB2 is
observed in brain. Lamin serves as loading
control.
(F) Survival of immortalized fibroblasts established
from TX/Y R26rtTA/rtTA embryos and infected with
SATB1 and SATB2 expression vector or control
empty vector (vector). The percent survival is
calculated from the cell number with Xist induction
relative to untreated cells (n = 6). Error bars repre-
sent standard deviation.
(G) Quantitative RT-PCR showing repression of
the X-linked Hprt and Pgk1 genes upon Xist induc-
tion in MEFs infected with SATB1 and SATB2 but
not empty vector controls. Expression relative
to Gapdh is plotted (n = 6). Error bars represent
standard deviation.similar to the endogenous Xi in differentiating female ES cells
(Figure S11A). Thus, SATB1 was expressed in the embryonic
context for X inactivation and could contribute to the initiation
of chromosome-wide silencing. However, disruption of SATB1
in mice is compatible with female development, suggesting
that other factors can take over its function in X inactivation
(Alvarez et al., 2000). To test if the close homolog SATB2 could
provide such a redundant function, we analyzed its expression
in ES cells. Similar to SATB1 we observed SATB2 expression
in ES cells (Figure 4C). After 3 days of differentiation, SATB2
showed a switch to a lower molecular weight. The higher molec-
ular weight likely corresponds to a SUMO-modified form that has
been previously described as important for gene regulation
(Dobreva et al., 2003). The shift in molecular weight at the end
of the initiation window of X inactivation suggested that the
higher molecular weight form of SATB2 could be important for
Xist mediated silencing.512 Developmental Cell 16, 507–516, April 21, 2009 ª2009 ElsevierTo further explore if SATB1 and SATB2 contribute to chromo-
some-wide silencing by Xist in ES cells we used RNAi . In clone
36 ES cells an inducible Xist transgene leads to repression of
a puromycine selection marker, which provides a convenient
readout for silencing (Wutz and Jaenisch, 2000). We transfected
either control, SATB1, SATB2, or a combination of SATB1 and
SATB2 siRNA into ES cells (Figure S11B). While there was little
effect of control, SATB1, or SATB2 siRNAs on cell numbers,
double RNAi of SATB1 and SATB2 led to a cell loss precluding
further analysis (Figures S11C and S11D). Analysis of puro
expression showed that silencing was efficient in control cells
with 13% of puro signal remaining after Xist induction. The effi-
ciency of silencing was reduced in cultures treated either with
SATB1 or SATB2 siRNAs, with 26% and 20% of puro message
remaining after Xist induction, respectively (Figure 4D). This
indicated that an acute loss of SATB1 and SATB2 reduced the
efficiency of gene silencing by Xist in ES cells. Furthermore,Inc.
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in ES cells confirming that the antiserum was specific (Figure 4E).
SATB2 expressed in the brain corresponds to the lower molec-
ular weight form, which we observed in differentiated ES cells
after the initiation window. We next asked if SATB1 or SATB2
are limiting for Xist silencing function in embryonic cells. We
previously reported that induction of Xist in embryonic fibro-
blasts (MEFs) does not cause gene silencing despite normal
Xist RNA localization (Wutz and Jaenisch, 2000). Thus, MEFs
lack essential initiation factors for Xist. To establish if either
SATB1 or SATB2 would perform as primary initiation factors in
the embryonic context, we virally expressed SATB1 in TX/Y
MEFs and tested if gene silencing could be restored. In
SATB1- and SATB2-infected MEFs cell numbers were signifi-
cantly reduced upon induction of Xist expression from the single
male X chromosome, whereasXist had no effect on cells infected
with a control virus (Figure 4F and Figure S12). Repression of the
X-linked Pgk1 and Hprt genes showed that Xist induction had
indeed led to ectopic X inactivation in SATB1- and SATB2-
infected MEFs (Figure 4G). We conclude that expression of
SATB1 or SATB2 substituted an essential primary initiation
factor and allowed to reestablish the embryonic context for
gene silencing by Xist in MEFs.
DISCUSSION
Here we identify SATB1 as a silencing factor for Xist. SATB1 is
required and sufficient for gene silencing by Xist in thymic
lymphoma cells. We find that SATB1 is expressed during the
initiation window of X inactivation in ES cells and its expression
is lost at the time point in differentiation when Xist can no longer
initiate chromosome-wide silencing. Importantly, viral SATB1
expression enables gene silencing by Xist in mouse embryonic
fibroblasts. Expression of SATB1 has also been observed in fetal
brain (Alvarez et al., 2000) and in erythroid differentiation (Wen
et al., 2005), which is consistent with our previous finding that
Xist induction leads to ablation of erythroid cells in mice (Savar-
ese et al., 2006). Mutation of SATB1 in mice leads to misregula-
tion of multiple genes during T cell development and arrests
development at the CD4+ CD8+ T cell stage (Alvarez et al.,
2000). The development of female mice in the absence of
SATB1 demonstrates that other factors can substitute SATB1
function in X inactivation. Thus, SATB1 contributes to X inactiva-
tion in embryonic cells together with other potentially as of yet
unidentified factors.
We find that one such factor could be SATB2. We observe
expression of SATB1 and SATB2 in ES cells. In western analysis
SATB1 migrates at its expected molecular weight, whereas there
is only a higher molecular weight band for SATB2. This higher
molecular weight band is specifically eliminated by SATB2
RNAi. These data are also consistent with immunofluorescence
staining showing SATB2 expression in ES cells, but not thymo-
cytes, which are positive for SATB1 (data not shown). From
this we conclude that there is a higher molecular weight form
of SATB2 in ES cells. From bioinformatics and SATB2 transcript
analysis we have not found evidence for additional SATB2
exons. From this we suggest that the higher molecular weight
results from posttranslational modification. This is consistent
with the shift on Day 2 of ES cell differentiation to the lowerDevemolecular weight form corresponding to the unmodified protein.
Albeit, western analysis suggests that the lower molecular
weight form in differentiated ES cells is more abundant than
the higher molecular weight SATB2 in ES cells, we note that
this might still be of functional significance since in ES cells
SATB1 is also present. Disruption of SATB2 is also compatible
with female development and causes skeletal abnormalities
and perinatal lethality in mice (Dobreva et al., 2006; Britanova
et al., 2006). SATB2 protein is expressed in the kidney (Dobreva
et al., 2003) and the nervous system (Britanova et al., 2005;
Dobreva et al., 2003), where we observe the lower molecular
form of SATB2 which is not relevant to Xist silencing and which
might have other functions. SATB2 expression is also reported
in pre-B cells (Dobreva et al., 2003), which are efficiently ablated
by Xist induction in mice (Savarese et al., 2006). The tissue distri-
bution of SATB1 and SATB2 expression is, thus, consistent with
a role in enabling chromosome silencing by Xist. So far, we have
not identified additional proteins with a high sequence homology
to SATB1 and SATB2 in the mouse genome. Albeit, more work is
needed to fully address if other factors than SATB1 and SATB2
contribute to the initiation of X inactivation in the embryo, our
data demonstrate a crucial contribution of SATB1 and SATB2
to chromosome-wide silencing by Xist and implicate a class of
proteins with functions in chromatin organization in the mamma-
lian dosage compensation mechanism.
Our finding that Xist spreads along the SATB1 ring in CD4+
CD8+ T cells suggests an interaction that links the localization
of SATB1 and Xist RNA. This observation could be made in
T cells where SATB1 shows a prominent ring- or cage-like stain-
ing pattern. In other cell types examined here, SATB1 shows
a more diffuse distribution, which makes localization analysis
less informative. We further made the intriguing observation
that induction of Xist from both X chromosomes in TX/TX female
thymocytes triggers a change in the localization pattern of
SATB1. In these cells SATB1 is localized from a cage-like pattern
toward the twoXist clusters. This mutual influence on localization
suggests that the relative robustness of either the SATB1 cage
structure or the chromosome territory organized by Xist deter-
mine the recruitment of SATB1 to the X chromosome or Xist
onto SATB1 cage structure.
At the initiation of X inactivation in ES cells we observe SATB1
surrounding the Xist domain. Albeit, the precise mechanism of
SATB1 in chromosome-wide silencing is not known at present,
we suggest a regulatory role of SATB1 for genic chromatin of
the X chromosome. SATB1 has been shown to organize tran-
scriptionally active chromatin into chromatin loops (Galande
et al., 2007; Cai et al., 2006). The X chromosome is organized
into a gene-rich outer rim and an internal core containing
silenced nongenic sequences (Clemson et al., 2006). Chaumeil
et al. (2006) showed that genes are moved into the chromosome
territory upon silencing in a manner that is dependent on repeat A
of Xist. It is possible that Xist pulls genes into the repressive core
compartment for silencing and SATB1 might act as an anchor in
this chromosomal reorganization.
Although we cannot completely rule out that SATB1 acts indi-
rectly in X inactivation via regulation of a target gene, we believe
that this is unlikely based on the following evidence: (1) Gain- and
loss-of-function experiments of SATB1 give the expected effect
on Xist mediated silencing in tumor cells. (2) Expression profileslopmental Cell 16, 507–516, April 21, 2009 ª2009 Elsevier Inc. 513
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other candidate genes with a chromatin regulatory function or
a plausible developmental expression pattern. (3) SATB1
expression in four different cell types enables gene silencing
by Xist. Since SATB2 also contributes to gene silencing by
Xist, we deem it extremely unlikely that a common SATB1 and
SATB2 target gene is regulating silencing in all cell systems. (4)
Our observation of mutual interaction between Xist and SATB1
localization in T cells supports a role of SATB1 in chromatin orga-
nization for the initiation of chromosome-wide silencing by Xist.
We have previously shown that the inactive X chromosome is
maintained during the stages in T cell and B cell development
when Xist can initiate silencing (Savarese et al., 2006). Since
Xist is delocalized in pre-T cells and very low expression is
observed in pre-B cells it is unlikely to contribute to maintaining
X inactivation. Since SATB1 can only cause chromosome-wide
silencing in combination with Xist, this fact strongly indicates
that SATB1 is not essential for Xi maintenance in pre-T cells.
Furthermore, the fact that the Xi is stably maintained in somatic
cells which do not express SATB1 further argues against
a general function of SATB1 in the maintenance of X inactivation.
Thus, SATB1 is an initiation factor but not a maintenance factor
for X inactivation.
SATB1 expression in thymic lymphoma suggests that the
epigenetic context of progenitor cells enabling Xist gene
silencing function is preserved in tumorigenesis. Progenitor-
derived leukemia stem cells have also been observed to maintain
progenitor identity and reactivate a self-renewal-associated
program (Krivtsov et al., 2006). We find SATB1 expressed in
a range of human lymphoma types including NPM-ALK positive
and negative ALCL (Table S2 and Figure S13). Expression of
SATB1 is further associated with more aggressive and poorly
differentiated forms of breast cancer in humans (Han et al.,
2008). These findings show that the Xist gene silencing pathway
is also tied in with tumorigenesis. This idea is further consistent
with the observation that XIST can initiate silencing in a human
fibrosarcoma cell line, at least to some extent (Chow et al.,
2007; Hall et al., 2002). Understanding the pathway enabling
chromosomal silencing by Xist in progenitors, thus, might open
new perspectives for cancer therapy.
EXPERIMENTAL PROCEDURES
Generation of NPM-ALKTumorsCarrying an InducibleXistAllele, TX
NPM-ALK X/Y transgenic mice (Chiarle et al., 2003) were crossed with TX/TX
R26rtTA/rtTA mice (Savarese et al., 2006) to obtain the desired genotypes
NPM-ALK TX/Y R26rtTA/rtTA and NPM-ALK TX/TX R26rtTA/rtTA. Tumor cells iso-
lated from thymic lymphoma were injected subcutaneously into both flanks of
6-week-old athymic Balb/c nu/nu mice. For each injection, 23 107 cells were
suspended in 250 ml cold PBS and 250 ml of cold BD Matrigel Basement
Membrane Matrix High Concentration (HC). For each experiment, 10 nude
mice were injected. Xist expression in tumor grafts was induced by administra-
tion of Doxycycline via the drinking water (1 g/l Doxycycline and 100 g/l
sucrose). Water bottles were protected from light and changed every second
day. Tumor development at the site of injection was measured daily. Error bars
throughout represent standard deviation unless stated otherwise. Tail vein
injection model: single-cell suspensions were prepared from the thymic
lymphoma NPM-ALK TX/Y R26rtTA/rtTA mice, and 1 3 106 lymphoma cells
were injected into the tail vein of 10 Rag2/ common-gamma chain cg/
mice. Five mice were administered Doxycycline and five were not treated.
Pathology was analyzed after 21 days.514 Developmental Cell 16, 507–516, April 21, 2009 ª2009 ElsevierCell Culture and Establishment of Lymphoma Cell Lines
ES cells and mouse embryonic fibroblasts were cultured as described previ-
ously (Wutz and Jaenisch, 2000). Xist expression was induced with 1 mg/ml
of Doxycycline. Lymphoma tumor cell lines were established from primary
NPM-ALK TX/TX R26rtTA/rtTA, NPM-ALK TX/Y R26rtTA/rtTA, and NPM-ALK X/Y
R26rtTA/rtTA lymphoma. Cells were cultured on murine bone marrow stromal-
derived OP9 feeders in IL-7 containing IMDM medium, as described (Hoflinger
et al., 2004).
Histology, Immunohistochemistry, and TUNEL Assay
Tumors and normal organs were fixed in 4% neutral buffered formaldehyde
at 4C and embedded in paraffin. Hematoxilin and eosin (H&E) staining was
performed on 3 mm sections. Immunohistochemistry was performed with anti-
bodies for ALK (mouse anti-ALK Mab; Zymed), anti-Ki-67 (NCL-Ki67p; Nova-
costra), or SATB1 (ab49061 Rabbit polyclonal anti-SATB1; Abcam). TUNEL
staining was performed by using the in situ cell death detection kit (Roche).
Clinical specimens were handled according to institutional guidelines.
RNA Extraction, Reverse Transcription PCR Analysis,
and Quantitative PCR Analysis
RNA was isolated using Trizol (Invitrogen, Life Technologies) and further puri-
fied using RNeasyTM columns (QIAGEN). Reverse transcription was primed
with Oligo(dT)12–18 using the SuperScript II RNase H- RT Kit (Invitrogen).
Quantitative PCR was performed for 40 cycles with SYBR Green on an Opticon
2 monitor fluorescence thermocycler (MJ Research, Waltham, MA). Relative
concentrations were determined on basis of standard curves of cDNA and
normalized for Gapdh. Melting curves were run to ensure amplification of
a single product. Error bars represent standard deviation. Primers for Pgk1,
Hprt, and Xist were previously published (Huynh and Lee, 2003). Primers for
SATB1 were CCTGGATGAGCCCTTTGG and CTGCGTGGTGGAACATTATG
and primers for mouse SATB2 were ACACCGACAACAGACCTC and
GGGCTTGAGACACCTTGG. Human SATB2 primers were as described (Han
et al., 2008).
Protein Extraction and Western Blotting
Whole cell extracts prepared with RIPA buffer and western analysis were
performed as previously published (Schoeftner et al., 2006) using rabbit
anti-SATB1 1:2000 (Dickinson et al., 1992) and SATB2 1:300 (ab34735 rabbit
anti-SATB2; Abcam).
Immunofluorescence, RNA FISH, and X Chromosome Painting
ES cells were attached to poly-l-lysine coated coverslips or cytospun using
a Cytospin 3 centrifuge (Thermo Shandon, USA). Differentiated cells were
grown on Roboz slides (CellPoint Scientific, USA). Lymphoma cells were
attached to adhesion slides (Marilienfeld, Germany). Immunostaining was
performed as described previously (Leeb and Wutz, 2007). In brief, cells
were fixed for 10 min in 4% PFA in PBS, permeabilized for 5 min in 0.1%
Na-citrate/0.5% Triton X-100, and blocked for 30 min in PBS containing 5%
BSA and 0.1% Tween 20. For H2AK119ub1 immunostaining, cells were
pre-extracted in 100 mM NaCl, 300 mM sucrose, 3 mM MgCl2, 10 mM Pipes
(pH 6.8), and 0.5% Triton X-100 for 2 min before fixation, and washes after
incubation with primary and secondary antibody were performed in KCM
buffer (120 mM KCl, 20 mM NaCl, 10 mM Tris [pH 8.0], and 0.5 mM EDTA)/
0.1% Tween 20. Antibodies and dilutions for Ring1B, Bmi1, H3K27me3, and
secondary antibodies were used as previously published (Leeb and Wutz,
2007). SATB1 antibody (Dickinson et al., 1992) was used in 1:500 dilution.
RNA FISH probes were generated by random priming (Stratagene) using
Cy3-dCTP (GE Healthcare). After immunostaining, cells were fixed in 4%
PFA in PBS for 10 min, dehydrated, hybridized, and washed as described
previously (Leeb and Wutz, 2007). Vectashield (Vector Laboratories) was
used as imaging medium. X chromosome painting was performed in tissue
sections as published (Donadoni et al., 2004) using a commercial probe (Cam-
bio). DAPI (40,60-diamidino-2-phenylindole) was used to stain the DNA.
Combined Xist RNA and X chromosome painting was performed sequentially
(Chaumeil et al., 2006) using a Cy3-labeled Xist probe and a biotin-labeled X
paint (Cambio). Images were obtained at room temperature with a fluores-
cence microscope (Axioplan; Zeiss), a CCD camera (CoolSNAP fx; Photomet-
rics), and MetaMorph image analysis software (Universal Imaging Corp.). ColorInc.
Developmental Cell
SATB1 Regulates Gene Silencing by Xist RNAlevels were adjusted in Photoshop 7.0 (Adobe). All confocal pictures were ob-
tained using a Zeiss LSM 510 Axiovert 200M. Deconvolution microscopy was
carried out on a DeltaVision Spectris Restoration Microscopy System (Applied
Precision) using a 1003 1.4 NA planachromat lens to collect a series of 0.2 mm
z-sections and subsequent deconvolution using the proprietary SoftWorx
algorithm (Applied Precision).
Expression Microarray and Bioinformatic Analysis
Total RNA was extracted using Trizol (Invitrogen) and whole genome expres-
sion profiles were generated using Affimetrix GeneChip Mouse Genome
430 2.0 arrays (RZPD, Germany). Data were submitted to the GEO repository
using the accession code GSE14585 (http://www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?acc=GSE14585). Microarray data were normalized using the
Robust Multi-Array Analysis as implemented in Bioconductor (Gentleman
et al., 2004; Irizarry et al., 2003). All analyses were performed with log2-trans-
formed data. Hypothesis tests were performed using a modified t statistics
with an empirical Bayes approach as implemented in the Bioconductor LIMMA
package (Smyth, 2004). The p values were adjusted by the FDR method of
Benjamini and Hochberg (1995). Unsupervised hierarchical clustering was
performed using the Unweighted Pair Group Method with Arithmetic Mean
(UPGMA) and the Pearson correlation coefficient distance measure. A batch
effect was removed with a mixed model ANOVA, and all probe sets were
ranked by their median absolute deviation. The 300 probe sets with the highest
median absolute deviation were selected and z-transformed before clustering.
RNA Interference
NPM-ALK TX/Y R26rtTA/rtTA lymphoma cells were transfected twice with
SATB1 siRNAs (Santa Cruz Biotechnology) or scrambled control siRNAs
(Santa Cruz Biotechnology) following the recommendations of the supplier.
Xist expression was induced by the addition of 1 mg/ml of Doxycycline 48 hr
after the first transfection for 5 days. Viable cell number was measured using
a CASY Cell Counter (Scha¨rfe System GmbH). Experiments were performed
in triplicate, and error bars plotted represent the standard deviation. For RNA
interference in ES cells, 23 104 cells were plated in a 6-well dish and incubated
for 24 hr. Subsequently, cells were transfected using 75 ml/well of 5 mM siRNA
(Santa Cruz Biotechnology) and 5 ml/well of Lipofectamlne 2000 (Invitrogen) in
OPTI-MEM (GIBCO) without serum. A second round of transfection was per-
formed after 3 days. Cells were then cultured for 48 hr in normal ES medium
either with or without Dox and analyzed by northern analysis as described
previously (Leeb and Wutz, 2007).
Cloning and Retrovirus Infections
The mouse SATB1 and human SATB2 cDNAs (RZPD, Germany) were cloned
into the MSCV-CD2 and pBabe-puro vectors. For virus production, Plat-E cells
were transfected with these vectors as described (Morita et al., 2000). The
supernatant was collected and used for infection of primary or immortalized
TX/Y R26rtTA/rtTA mouse embryonic fibroblasts. Infected cells were selected
with Puromycin or sorted by FACS after staining with phycoeritrin (PE) anti-
human CD2 (eBioscience) using a FACS Aria cell sorter (Becton Dickinson).
ACCESSION NUMBERS
Gene expression profiles have been deposited at GEO with the accession
code GEO14585.
SUPPLEMENTAL DATA
Supplemental Data include thirteen figures and two tables and can be
found with this article online at http://www.cell.com/developmental-cell/
supplemental/S1534-5807(09)00096-3.
ACKNOWLEDGMENTS
We thank Gabi Stengl for FACS analysis, Pavel Pasierbek for help with miro-
scopy, Johannes Tkadletz for figure preparation, Andreas Bichl and Denise
Imre for maintenance of the mouse colony, and Erwin F. Wagner, Denise
Barlow, and Joseph Penninger for critically reading the mansucript. We thankDeveMasaru Miyano for thymic cell preparations. This research was supported by
a grant from the Vienna Science and Technology Fund (WWTF), by the IMP
through Boehringer Ingelheim, and the Austrian Science Fund (FWF). The
IMP is funded in part through Boehringer Ingelheim and C.H. is employed by
Boehringer Ingelheim.
Received: November 17, 2008
Revised: February 12, 2009
Accepted: March 3, 2009
Published: April 20, 2009
REFERENCES
Alvarez, J.D.,Yasui, D.H.,Niida, H., Joh, T., Loh, D.Y., andKohwi-Shigematsu, T.
(2000). The MAR-binding protein SATB1 orchestrates temporal and spatial
expression of multiple genes during T-cell development. Genes Dev. 14,
521–535.
Azuma, M., Hirao, A., Takubo, K., Hamaguchi, I., Kitamura, T., and Suda, T.
(2005). A quantitative matrigel assay for assessing repopulating capacity of
prostate stem cells. Biochem. Biophys. Res. Commun. 338, 1164–1170.
Benjamini, Y., and Hochberg, Y. (1995). Controlling the false discovery rate:
a practical and powerful approach to multiple testing. Journal of the Royal
Statistical Society Series, 289–300.
Blewitt, M.E., Gendrel, A.V., Pang, Z., Sparrow, D.B., Whitelaw, N., Craig, J.M.,
Apedaile, A., Hilton, D.J., Dunwoodie, S.L., Brockdorff, N., et al. (2008).
SmcHD1, containing a structural-maintenance-of-chromosomes hinge
domain, has a critical role in X inactivation. Nat. Genet. 40, 663–669.
Britanova, O., Akopov, S., Lukyanov, S., Gruss, P., and Tarabykin, V. (2005).
Novel transcription factor Satb2 interacts with matrix attachment region
DNA elements in a tissue-specific manner and demonstrates cell-type-depen-
dent expression in the developing mouse CNS. Eur. J. Neurosci. 21, 658–668.
Britanova, O., Depew, M.J., Schwark, M., Thomas, B.L., Miletich, I., Sharpe, P.,
and Tarabykin, V. (2006). Satb2 haploinsufficiency phenocopies 2q32-q33
deletions, whereas loss suggests a fundamental role in the coordination of
jaw development. Am. J. Hum. Genet. 79, 668–678.
Brown, C.J., and Willard, H.F. (1994). The human X-inactivation centre is
not required for maintenance of X-chromosome inactivation. Nature 368,
154–156.
Cai, S., Han, H., and Kowhi-Shigematsu, T. (2003). Tissue-specific nuclear
architecture and gene function regulated by SATB1. Nat. Genet. 34, 42–51.
Cai, S., Lee, C.C., and Kohwi-Shigematsu, T. (2006). SATB1 packages densely
looped, transcriptionally active chromatin for coordinated expression of cyto-
kine genes. Nat. Genet. 38, 1278–1288.
Chaumeil, J., Le Baccon, P., Wutz, A., and Heard, E. (2006). A novel role for Xist
RNA in the formation of a repressive nuclear compartment into which genes
are recruited when silenced. Genes Dev. 20, 2223–2237.
Chiarle, R., Gong, J.Z., Guasparri, I., Pesci, A., Cai, J., Liu, J., Simmons, W.J.,
Dhall, G., Howes, J., Piva, R., et al. (2003). NPM-ALK transgenic mice sponta-
neously develop T-cell lymphomas and plasma cell tumors. Blood 101,
1919–1927.
Chiarle, R., Voena, C., Ambrogio, C., Piva, R., and Inghirami, G. (2008). The
anaplastic lymphoma kinase in the pathogenesis of cancer. Nat. Rev. Cancer
8, 11–23.
Chow, J.C., Hall, L.L., Baldry, S.E., Thorogood, N.P., Lawrence, J.B., and
Brown, C.J. (2007). Inducible XIST-dependent X-chromosome inactivation in
human somatic cells is reversible. Proc. Natl. Acad. Sci. USA 104,
10104–10109.
Clemson, C.M., Hall, L.L., Byron, M., McNeil, J., and Lawrence, J.B. (2006).
The X chromosome is organized into a gene-rich outer rim and an internal
core containing silenced nongenic sequences. Proc. Natl. Acad. Sci. USA
103, 7688–7693.
Costanzi, C., and Pehrson, J.R. (1998). Histone macroH2A1 is concentrated in
the inactive X chromosome of female mammals. Nature 393, 599–601.lopmental Cell 16, 507–516, April 21, 2009 ª2009 Elsevier Inc. 515
Developmental Cell
SATB1 Regulates Gene Silencing by Xist RNACsankovszki, G., Panning, B., Bates, B., Pehrson, J.R., and Jaenisch, R.
(1999). Conditional deletion of Xist disrupts histone macroH2A localization
but not maintenance of X inactivation. Nat. Genet. 22, 323–324.
Dickinson, L.A., Joh, T., Kowhi, Y., and Kohwi-Shigematsu, T. (1992). A tissue-
specific MAR/SAR binding protein with unusual binding site recognition. Cell
70, 631–645.
Dobreva, G., Dambacher, J., and Grosschedl, R. (2003). SUMO modification of
a novel MAR-binding protein, SATB2, modulates immunoglobulin mu gene
expression. Genes Dev. 17, 3048–3061.
Dobreva, G., Chahrour, M., Dautzenberg, M., Chirivella, L., Kanzler, B.,
Farinas, I., Karsenty, G., and Grosschedl, R. (2006). SATB2 is a multifunctional
determinant of craniofacial patterning and osteoblast differentiation. Cell 125,
971–986.
Donadoni, C., Corti, S., Locatelli, F., Papadimitriou, D., Guglieri, M., Strazzer, S.,
Bossolasco, P., Salani, S., and Comi, G.P. (2004). Improvement of combined
FISH and immunofluorescence to trace the fate of somatic stem cells after
transplantation. J. Histochem. Cytochem. 52, 1333–1339.
Galande, S., Purbey, P.K., Notani, D., and Kumar, P.P. (2007). The third dimen-
sion of gene regulation: organization of dynamic chromatin loopscape by
SATB1. Curr. Opin. Genet. Dev. 17, 408–414.
Gentleman, R.C., Carey, V.J., Bates, D.M., Bolstad, B., Dettling, M., Dudoit, S.,
Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004). Bioconductor: open soft-
ware development for computational biology and bioinformatics. Genome
Biol. 5, R80.
Hall, L.L., Byron, M., Sakai, K., Carrel, L., Willard, H.F., and Lawrence, J.B.
(2002). An ectopic human XIST gene can induce chromosome inactivation in
postdifferentiation human HT-1080 cells. Proc. Natl. Acad. Sci. USA 99,
8677–8682.
Han, H.J., Russo, J., Kohwi, Y., and Kohwi-Shigematsu, T. (2008). SATB1
reprogrammes gene expression to promote breast tumour growth and metas-
tasis. Nature 452, 187–193.
Hoflinger, S., Kesavan, K., Fuxa, M., Hutter, C., Heavey, B., Radtke, F., and
Busslinger, M. (2004). Analysis of Notch1 function by in vitro T cell differentia-
tion of Pax5 mutant lymphoid progenitors. J. Immunol. 173, 3935–3944.
Huynh, K.D., and Lee, J.T. (2003). Inheritance of a pre-inactivated paternal X
chromosome in early mouse embryos. Nature 426, 857–862.
Irizarry, R.A., Bolstad, B.M., Collin, F., Cope, L.M., Hobbs, B., and Speed, T.P.
(2003). Summaries of Affymetrix GeneChip probe level data. Nucleic Acids
Res. 31, e15.
Keohane, A.M., O’Neill, L.P., Belyaev, N.D., Lavender, J.S., and Turner, B.M.
(1996). X-Inactivation and histone H4 acetylation in embryonic stem cells.
Dev. Biol. 180, 618–630.
Krivtsov, A.V., Twomey, D., Feng, Z., Stubbs, M.C., Wang, Y., Faber, J.,
Levine, J.E., Wang, J., Hahn, W.C., Gilliland, D.G., et al. (2006). Transformation
from committed progenitor to leukaemia stem cell initiated by MLL-AF9.
Nature 442, 818–822.516 Developmental Cell 16, 507–516, April 21, 2009 ª2009 ElsevierLeeb, M., and Wutz, A. (2007). Ring1B is crucial for the regulation of develop-
mental control genes and PRC1 proteins but not X inactivation in embryonic
cells. J. Cell Biol. 178, 219–229.
Marahrens, Y., Panning, B., Dausman, J., Strauss, W., and Jaenisch, R. (1997).
Xist-deficient mice are defective in dosage compensation but not spermato-
genesis. Genes Dev. 11, 156–166.
Mermoud, J.E., Costanzi, C., Pehrson, J.R., and Brockdorff, N. (1999). Histone
macroH2A1.2 relocates to the inactive X chromosome after initiation and
propagation of X-inactivation. J. Cell Biol. 147, 1399–1408.
Morita, S., Kojima, T., and Kitamura, T. (2000). Plat-E: an efficient and stable
system for transient packaging of retroviruses. Gene Ther. 7, 1063–1066.
Morris, S.W., Kirstein, M.N., Valentine, M.B., Dittmer, K.G., Shapiro, D.N.,
Saltman, D.L., and Look, A.T. (1994). Fusion of a kinase gene, ALK, to a nucle-
olar protein gene, NPM, in non-Hodgkin’s lymphoma. Science 263,
1281–1284.
Penny, G.D., Kay, G.F., Sheardown, S.A., Rastan, S., and Brockdorff, N. (1996).
Requirement for Xist in X chromosome inactivation. Nature 379, 131–137.
Plath, K., Fang, J., Mlynarczyk-Evans, S.K., Cao, R., Worringer, K.A., Wang, H.,
de la Cruz, C.C., Otte, A.P., Panning, B., and Zhang, Y. (2003). Role of histone
H3 lysine 27 methylation in X inactivation. Science 300, 131–135.
Rasmussen, T.P., Mastrangelo, M.A., Eden, A., Pehrson, J.R., and Jaenisch,
R. (2000). Dynamic relocalization of histone MacroH2A1 from centrosomes
to inactive X chromosomes during X inactivation. J. Cell Biol. 150, 1189–1198.
Sado, T., Fenner, M.H., Tan, S.S., Tam, P., Shioda, T., and Li, E. (2000).
X inactivation in the mouse embryo deficient for Dnmt1: distinct effect of hypo-
methylation on imprinted and random X inactivation. Dev. Biol. 225, 294–303.
Sado, T., Okano, M., Li, E., and Sasaki, H. (2004). De novo DNA methylation is
dispensable for the initiation and propagation of X chromosome inactivation.
Development 131, 975–982.
Savarese, F., Flahndorfer, K., Jaenisch, R., Busslinger, M., and Wutz, A. (2006).
Hematopoietic precursor cells transiently reestablish permissiveness for X
inactivation. Mol. Cell. Biol. 26, 7167–7177.
Schoeftner, S., Sengupta, A.K., Kubicek, S., Mechtler, K., Spahn, L., Koseki, H.,
Jenuwein, T., and Wutz, A. (2006). Recruitment of PRC1 function at the initiation
of X inactivation independent of PRC2 and silencing. EMBO J. 25, 3110–3122.
Smyth, G.K. (2004). Linear models and empirical bayes methods for assessing
differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol.
3, Article3.
Wen, J., Huang, S., Rogers, H., Dickinson, L.A., Kohwi-Shigematsu, T., and
Noguchi, C.T. (2005). SATB1 family protein expressed during early erythroid
differentiation modifies globin gene expression. Blood 105, 3330–3339.
Wutz, A., and Jaenisch, R. (2000). A shift from reversible to irreversible X inac-
tivation is triggered during ES cell differentiation. Mol. Cell 5, 695–705.
Wutz, A., Rasmussen, T.P., and Jaenisch, R. (2002). Chromosomal silencing
and localization are mediated by different domains of Xist RNA. Nat. Genet.
30, 167–174.Inc.
